Researchers are seeking thousands of volunteers in the United States and Europe to test the first potential vaccine against Lyme disease in 20 years — in hopes of better fighting the tick-borne ...
Certain concerns have hindered development, but several Lyme prevention drugs are currently being tested in humans.
The French biotech company Valneva and the pharmaceutical company Pfizer have paired together to test out a Lyme vaccine for humans with the working name VLA15. The vaccine “has demonstrated a ...
Lyme disease vaccine was well tolerated in both children and adults, regardless of vaccination schedule or dose. The majority of adverse events were transient and mild to moderate in severity in ...
although greater awareness and increased testing are relevant.” There could be soon. Pharmaceutical giant Moderna said it is developing two new mRNA vaccines that could prevent Lyme disease, ...
Yet COVID-19 vaccines were developed in less than a year ... It's similar to a medication used for treating the HIV virus. Lyme PrEP is only at a very early stage of clinical testing. known as phase 1 ...
A vaccine for Lyme disease is not currently available, but two scientific initiatives to fight the condition are showing promising results, with one soon to be rolled out. Borrelia burgdorferi ...
Diagnosing patients with neurologic Lyme disease can take upwards of 2 years, which Maria Arini Lopez discovered first-hand ...
France could be one step closer to a vaccine against Lyme disease after researchers published promising new results from a ...
Thomas Lingelbach, CEO of French vaccine specialist Valneva, said that the company is focused on launching its newly approved ...
The Centers for Disease Control and Prevention (CDC) — the federal agency that monitors diseases and establishes guidelines ...
In 2017, a French company called Valneva started testing a Lyme disease vaccine on adults in the U.S. and Europe. The vaccine is in the third and final phase of clinical trials. Your dog is much ...